ALK-Abello A/S - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for ALK-Abello A/S. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

ALK-Abello A/S. The principal activity of the Group is developing products for diagnosis, prevention and treatment of allergies. The Group operates through one business area namely: Allergy sector. The Allergy sector operates within allergy vaccination - injection-based and drop-based vaccines, the only treatment able to cure allergy rather than just alleviate symptoms. In addition to the existing business, the Group has developed a pipeline of projects which have the potential to bring crucial, innovative change to the treatment and cure of allergy. The Group operates subsidiaries in France, Netherlands, Italy, Sweden, Germany, UK and USA, and has sales offices in China, Finland, Norway and Denmark. In 2008 the Group acquired Western Allergy Services Ltd. and allergy vacinationation activities of its former distributior in cannada.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report